Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND application for phase I study of FX-201

Nov. 4, 2019

Daiichi Sankyo and Sarah Cannon initiate first-in-human study of DS-7300

Nov. 4, 2019

FDA approves IND for first-in-human study of affinity-tuned CAR-T cell product AIC-100

Nov. 4, 2019

NTS2-selective compounds with promising activity in preclinical models of pain

Nov. 4, 2019

Novel miRNA biomarker panel for predicting mortality in pediatric patients with ARDS

Nov. 4, 2019

Progranulin as new risk biomarker for the development of sepsis

Nov. 4, 2019

Novel CAR.CD30 T-cell therapy shows potential in vivo activity

Nov. 4, 2019

Serum endocan as biomarker to predict postablation recurrence of HCC

Nov. 4, 2019

CTLA-4 plus PD-1 equals more than the sum of its parts

Nov. 4, 2019

Millennium Pharmaceuticals initiates phase I/II study of TAK-981 plus rituximab in NHL

Oct. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...